Clinical Trial Update: Maitake for Integrative Cancer Care [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Maitake mushroom extract for integrative cancer care and is currently recruiting. The sponsor listed is The Canadian Coll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Maitake mushroom extract (Maitake mushroom extract)

Snippet

Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Cancer | Phase 2 | Status: RECRUITING